About NDA


Translational Science

NDA Advisory Board

Regulatory Affairs


High-Stakes Meetings

Health Technology Assessment


What do we need to know before the next influenza pandemic?

9th October 2019

Earlier this year the 2nd International Alliance of Biological Science meeting was held to review the status of the current knowledge regarding the relationship between narcolepsy and the administration of the adjuvanted pandemic influenza vaccines, especially Pandemrix.


Let’s celebrate the launch of our new service: NDA Accelerator!

2nd October 2019

On the 21st of October we will be launching our new NDA Accelerator service in The Nordics and we think this is well worth celebrating, so why not join our team on Friday the 18th of October for drinks, snacks and networking of course.


Meet the NDA Experts in October

25th September 2019

October is a busy month for our NDA experts and there are plenty of opportunities to meet them and discuss your challenges within regulatory and drug development.


Navigating the Regulatory Maze – Early Stage Development Strategies

24th September 2019

Welcome to NDA’s seminar on 31st October 10:00-12:00 in Zürich, Switzerland, on Navigating the Regulatory Maze – Early Stage Development Strategies


Webinar – Integrated Product Development for ATMPs to Meet Regulatory and HTA Requirements

9th September 2019

Join us on 3rd October for this engaging webinar where NDAs Paula Salmikangas and Claes Buxfeldt will describe an integrated product development process for ATMPs to ensure a positive path from clinical trials up to pricing and reimbursement..


Robert Kronqvist joins NDA Group as General Manager Nordics

20th August 2019

We a happy to announce and welcome Robert Kronqvist to the NDA team as General Manager for our Nordic affiliate head-quartered in Stockholm, Sweden.


Global capabilities for local growth

31st July 2019

In this commentary, NDA’s Johan Strömquist and Thomas Lönngren provide their reflections on the unique opportunities the Nordics present for the Life Science sector.

More News
We have helped over 2,000 clients achieve success in the past
We have helped over 2,000 clients achieve success in the past

The leader in FDA Advisory Committee meeting preparation

“For innovative life science companies, NDA and PharmApprove are the best partners to help prepare to win at FDA Advisory Committees. Our pioneering approach — refined over 16 years experience and 150-plus projects — has helped more than 80 clients achieve success at these high-profile, high-stakes hearings.

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.


A Career with NDA

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance, health technology assessment and scientific communications on a variety of projects, clients and geographies.

Why work at NDA?

Our Locations

NDA Sweden

NDA Group AB
Johanneslundsv. 2
S-194 61 Upplands Väsby

T. +46 (0)8 590 778 00
E. stockholm@ndareg.com

NDA France

7, rue Jobbé Duval,
75015 Paris,

T. +33 983 981 942
E. paris@ndareg.com

NDA Germany

Neumarkter Straße 18
D-81673 München

T. +49 (0)89 3585 4000
E. munich@ndareg.com

NDA Switzerland

Rigistrasse 5
8703 Erlenbach

T. +41 (0)78 951 9929
E. zurich@ndareg.com


Grove House
Guildford Road
Surrey KT22 9DF
United Kingdom

T. +44 (0) 1372 860 610
E. london@ndareg.com

NDA USA Massachusetts

NDA Regulatory Development Inc.
1 Broadway, 14th floor
Cambridge, MA 02142
United States

T. +1 609 583 1990
E. usa@ndareg.com

NDA USA New Jersey

200 Princeton South Corporate Center,
Suite 340
Ewing, NJ 08628
United States

T. +1 609 583 1990
E. usa@ndareg.com